BACK TO CONTENTS   |    PDF   |    PREVIOUS   |    NEXT


Title

Identification of inhibitors against α-Isopropylmalate Synthase of Mycobacterium tuberculosis using docking-MM/PBSA hybrid approach

 

Authors

Preeti Pandey, Andrew M. Lynn*, Pradipta Bandyopadhyay*

 

Affiliation

School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi, INDIA 110067;

 

Email

andrew@jnu.ac.in; praban07@gmail.com

 

Article Type

Hypothesis

 

Date

Received April 18, 2017; Accepted April 21, 2017; Published May 31, 2017

 

Abstract

α-Isopropylmalate Synthase (α-IPMS) encoded by leuA in Mycobacterium tuberculosis (M.tb) is involved in the leucine biosynthesis pathway and is extremely critical for the synthesis of branched-chain amino acids (leucine, isoleucine and valine). α-IPMS activity is required not only for the proliferation of M.tb but is also indispensable for its survival during the latent phase of infection. It is absent in humans and is widely regarded as one of the validated drug targets against Tuberculosis (TB). Despite its essentiality, any study on designing of potential chemical inhibitors against α-IPMS has not been reported so far. In the present study, in silico identification of putative inhibitors against α-IPMS exploring three chemical databases i.e. NCI, DrugBank and ChEMBL is reported through structure based drug design and filtering of ligands based on the pharmacophore feature of the actives. In the absence of experimental results of any inhibitor against α-IPMS, a stringent validation of docking results is done by comparing with molecular mechanics/Poisson-Boltzmann surface area (MM/PBSA) calculations by investigating two more proteins for which experimental results are known.

 

Keywords

Inhibitor, α-Isopropylmalate Synthase, Mycobacterium tuberculosis, docking-MM/PBSA hybrid approach

 

Citation

Pandey et al. Bioinformation 13(5): 144-148 (2017)

 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.